Enalare Therapeutics Invited to Present at Upcoming Biotech Conferences

Enalare Therapeutics Inc., a biopharmaceutical company dedicated to developing novel therapies for patients suffering from life-threatening critical care conditions, announced today that it has been invited to present at both the H.C. Wainright Bioconnect Conference and the Biotech Showcase 2022 Conference. Herm Cukier, President and CEO of Enalare Therapeutics, will provide an update on the … Read more

SiO2 Materials Science and Oaktree Enter Into Refinancing and Expansion of Senior Debt Facility to Accelerate Growth

SiO2 Materials Science (SiO2), an advanced materials science corporation introducing a breakthrough disruptive technology platform serving the biopharma, molecular diagnostic, and consumer healthcare industries, today announced that it has successfully entered in a new $205 million five year facility provided by funds managed by Oaktree Capital Management, L.P. (“Oaktree”).  Proceeds of the facility will be … Read more

Qualer Has Added New Automation Software Features for Their Asset Maintenance Software Solutions

 Qualer has created a unique ecosystem that combines and synergizes all work around asset, service and vendor management. By using Qualer’s asset maintenance software, companies eliminate redundancy data entry, create a system of checks and balances, and allow for a greater degree of software automation. Qualer provides a solution with a singular focus: shaping the … Read more

SiO2 Materials Science and Doosan Corporation Enter Into Strategic Partnership to Accelerate Market Development in Asia

Doosan Corporation, founded in 1896, one of South Korea’s largest diversified conglomerates, and SiO2 Materials Science, a privately-owned U.S. advanced materials science corporation introducing breakthrough disruptive technology for packaging biological pharmaceuticals and vaccines, today announced an exclusive partnership to sell, market, and distribute SIO2’s vial, syringes and blood collection tubes in Asia/Oceania. The partnership will … Read more

Hyris Fully Embraces the Immunology Sector to Better Fight COVID-19 and Beyond, Presenting Its New, Disruptive T-Cell Test to the International Conference ‘A-Wish’

As the COVID-19 pandemic keeps causing concerns, with new variants spreading worldwide, it is now widely recognized that we must move beyond a “test&trace” only approach. World leaders and health institutions today aim to achieve high immunity rates among the population, facing the unprecedented challenge of a worldwide vaccination campaign against an emerging virus, for … Read more

Courier Health Named One of the Most Innovative Startups of 2021 by PM360

PM360, a leading trade magazine for marketing decision-makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has named Courier Health as one of the most innovative Startups of 2021. Founded in 2020, Courier Health is rapidly rising as the preferred software platform for Patient Engagement and Support in the life sciences industry. Courier Health’s … Read more

Aronora Announces Clinical Data to Be Presented at the 63rd American Society of Hematology Annual Meeting

Aronora Inc., a clinical-stage biotechnology company developing innovative therapies for hematologic diseases, today announced that clinical data from its completed phase 2 study of AB002 will be presented at the 63rd American Society of Hematology (ASH) Annual Meeting Dec. 11-14, 2021, taking place both virtually and in Atlanta, Georgia. Dr. Joseph Shatzel, Assistant Professor of … Read more

Canadian Online Pharmacies Reduce Medication Costs

For many years now, lower-middle-class families in America have struggled with the high costs associated with prescription medication. Individuals and families who struggle to afford medication are now ordering their medications from online pharmacies in Canada like Canada Pharmacy. Canada Pharmacy offers the same medications that are sold at conventional pharmacies, but at a fraction … Read more

H.R.3 Elijah E. Cummings Lower Drugs Costs Now Act to Lower Rx Prices

Longstanding federal legislation in the USA has prevented Medicare from negotiating drug prices directly with manufacturers. This legislation has been pointed to as one of the reasons medications covered under Medicare Part D are typically regarded as too expensive and out of budget for lower-income American seniors. Although it is seniors who struggle most with … Read more